跳至主要内容
临床试验/CTRI/2023/11/060110
CTRI/2023/11/060110尚未招募4 期

An open randomised control clinical study of Nisha Amalaki extract in Prediabetic with special reference to Prameha.

DR SAJIDA D ATTAR0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Having IDRS score more than 50.
  • 2)HbA1c level of 5.7-6.4%
  • 3)A fasting blood Sugar level (FBS) of 110-125 mg/dL ; (fasting is done as no caloric intake for at least 8 hours.)
  • 4)A 2-hour Blood Sugar level (PPBS) of 140 to 199 mg/dL .

排除标准

  • 1.Exclusion criteria included people currently using oral hypoglycemic agents (OHAs); those reporting prior use of medication to treat diabetes mellitus.
  • 2.Type ll Diabetes Mellitus (NIDDM)
  • 3.Type l Diabetes Mellitus (IDDM)
  • 4.Subjects giving history of signicant cardiovascular event < 12 weeks prior to study
  • 5.Subjects with known Chronic Infectious Disease, such as active Tuberculosis, Hepatitis B or C, or HIV.
  • 6.Pregnant female and lactating mother

研究者

发起方
DR SAJIDA D ATTAR

相似试验

Clinical study of Nisha Amalaki extract in... | 临床试验